Table 3 Overview of the worldwide approved different types of COVID-19 vaccines
From: COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy
Vaccine | Product name | Vaccine type | Phase III efficacy | Doses | Storage | Prize per dose | Distribution |
|---|---|---|---|---|---|---|---|
BioNTech/Pfizer | BNT162b2 | mRNA | 95% | 2 doses (0.3 mL) [21 days apart] | −80 and −60 °C (−112 and −76 °F) for 6 months +2 and +8 °C (+36 and +46 °F) for 5 days | 19.5 $ | USA, EU, UK, Argentina, Australia, Bahrain, Canada, Chile, Costa Rica, Ecuador, Hong Kong, Iraq, Israel, Jordan, Kuwait, Malaysia, Mexico, Oman, Panama, Philippines, Qatar, Saudi Arabia, Singapore, South Korea, United Arab Emirates COVAX (COVID-19 Vaccines Global Access) |
Moderna | mRNA-1273 | mRNA | 94.1% | 2 doses (0.5 mL) [28 days apart] | −20 °C (−4 °F) for 4 months +2 and +8 °C (+36 and +46 °F) for 30 days | 32-37 $ | USA, EU, UK, Canada, Greenland, Iceland, Israel, Saudi Arabia, Singapore, Vietnam COVAX (COVID-19 Vaccines Global Access) |
Oxford/AstraZeneca | ChAdOx1 AZD1222/Vaxzevria | Viral vector | 81.3% | 2 doses (0.5 mL) [10-12 weeks apart] | +2 and +8 °C (+36 and +46 °F) | 1.5-4 $ | USA, EU, UK, Australia, Bangladesh, Brazil, Canada, Greenland, India, Mexico, Nepal, Pakistan, Philippines, Sri Lanka, Taiwan, Vietnam COVAX (COVID-19 Vaccines Global Access) |
Gamaleya (Sputnik V) | Sputnik V Gam-Covid-Vac | Viral vector | 91.6% | 2 doses (0.5 mL) [28 days apart] | −18 °C (0 °F) for 24 months +2 and +8 °C (+36 and +46 °F) for 3 months | < 10 $ | Russia, India, Brazil, China, South Korea, Hungary, Argentina |
Johnson&Johnson | JNJ-78436735 Ad26.COV2.S | Viral vector | 72% | 1 dose | −18 °C (0 °F) for 24 months +2 and +8 °C (+36 and +46 °F) for 3 months | 10 $ | USA, EU, Greenland, Canada COVAX (COVID-19 Vaccines Global Access) |
Novavax | NVX-CoV2373 | Virus-like particle | 89% | 2 doses [21 days apart] | −18 °C (0 °F) for 24 months +2 and +8 °C (+36 and +46 °F) for 3 months | 16 $ | USA, Canada |
Sinopharm | BBIBP-CorV | Inactivated virus | 78% | 2 doses [3 weeks apart] | +2 and +8 °C (+36 and +46°F) Three years in storage | < 77 $ | China, United Arab Emirates, Argentina, Bahrain, Egypt, Marocco, Pakistan, Perù |
SinoVac | CoronaVac | Inactivated virus | 50% | 2 doses [3 weeks apart] | 2-8 °C (36-46 °F) Three years in storage | 14 $ | China, Brazil, Turkey, Chile, Indonesia, Philippines |
Covaxin (Bharat Biontech) | BBV152 | Inactivated virus | 81% | 2 doses [21 days apart] | 2-8 °C (36-46 °F) Three years in storage | 1 $ | India, Iran, Mauritius, Nepal, Zimbabwe |